Skip to main content
PROK logo

ProKidney Corp.

PROKNASDAQHealthcareBiotechnology

$1.41Today:- (-)1Y −55.17%

As of Oct 23, 2026 close

Market cap
$263.05M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.30$3.48
Volume (live)
-
Avg. volume (3M)
1.51M

ProKidney Corp. (PROK) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for ProKidney Corp. stock.

Analyst Consensus Rating

Investment consensus from 5 professional research analysts

Consensus Rating

Buy
Based on 5 unique analysts
(6 total ratings in last 90 days)
Medium Confidence2.0:1 Buy/Sell

Average Price Target

$5.75
+307.80% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PROK Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Dina Ramadane
BofA Securities
SellMaintains
$1.00
Anupam Rama
JP Morgan
HoldMaintains
-
Unknown Analyst
Guggenheim
BuyMaintains
$7.00
Joseph Pantginis
HC Wainwright
BuyMaintains
$12.00
Dina Ramadane
BofA Securities
SellReiterates
$1.00
Judah Frommer
Morgan Stanley
HoldMaintains
$3.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 12, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PROK?

The analyst consensus rating for PROK is Buy, based on the latest ratings from 5 analysts over the last 90 days.

What is the average price target for PROK?

The average 12-month price target for PROK is $5.75, representing an upside of 307.8% from the Oct 23, 2026 close of $1.41.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.